» Articles » PMID: 18752571

Adhesive Receptors, Extracellular Proteins and Myosin IIA Orchestrate Proplatelet Formation by Human Megakaryocytes

Overview
Publisher Elsevier
Specialty Hematology
Date 2008 Aug 30
PMID 18752571
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Megakaryocytes release platelets from the tips of cytoplasmic extensions, called proplatelets. In humans, the regulation of this process is still poorly characterized.

Objective: To analyse the regulation of proplatelet formation by megakaryocyte adhesion to extracellular adhesive proteins through different membrane receptors.

Methods: Human megakaryocytes were obtained by differentiation of cord blood-derived CD34(+) cells, and proplatelet formation was evaluated by phase contrast and fluorescence microscopy.

Results: We found that human megakaryocytes extended proplatelets in a time-dependent manner. Adhesion to fibrinogen, fibronectin or von Willebrand factor (VWF) anticipated the development of proplatelets, but dramatically limited both amplitude and duration of the process. Type I, but not type III or type IV, collagen totally suppressed proplatelet extension, and this effect was overcome by the myosin IIA antagonist blebbistatin. Integrin alphaIIbbeta3 was essential for megakaryocyte spreading on fibrinogen or VWF, but was not required for proplatelet formation. In contrast, proplatelet formation was prevented by blockade of GPIb-IX-V, or upon cleavage of GPIbalpha by the metalloproteinase mocarhagin. Membrane-associated VWF was detected exclusively on proplatelet-forming megakaryocytes, but not on round mature cells that do not extend proplatelets.

Conclusions: Our findings show that proplatelet formation in human megakaryocytes undergoes a complex spatio-temporal regulation orchestrated by adhesive proteins, GPIb-IX-V and myosin IIA.

Citing Articles

-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches.

Shen K, Chen T, Xiao M Res Pract Thromb Haemost. 2024; 8(6):102552.

PMID: 39309229 PMC: 11415342. DOI: 10.1016/j.rpth.2024.102552.


Inside-to-outside and back to the future of megakaryopoiesis.

Di Buduo C, Miguel C, Balduini A Res Pract Thromb Haemost. 2023; 7(4):100197.

PMID: 37416054 PMC: 10320384. DOI: 10.1016/j.rpth.2023.100197.


Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome.

Grodzielski M, Cidlowski J J Thromb Haemost. 2023; 21(11):3207-3223.

PMID: 37336437 PMC: 10592358. DOI: 10.1016/j.jtha.2023.06.012.


Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis.

Marin-Quilez A, Di Buduo C, Diaz-Ajenjo L, Abbonante V, Vuelta E, Soprano P Blood. 2022; 141(4):406-421.

PMID: 36395340 PMC: 10644051. DOI: 10.1182/blood.2022016995.


The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its relevance for cancer development and metastasis.

Bendas G, Schlesinger M Exp Hematol Oncol. 2022; 11(1):19.

PMID: 35366951 PMC: 8976409. DOI: 10.1186/s40164-022-00273-2.